Duncan Greenhalgh

Duncan Greenhalgh is a senior partner in Goodwin's nationally recognized Life Sciences group where he counsels companies, entrepreneurs, investors, and investment banks on intellectual property matters. His practice focuses on developing and implementing complex intellectual property and market exclusivity strategies for emerging and mature life sciences companies, with a focus on maximizing exclusivity for biologic and chemical therapeutics. While he focuses on US and ex-US patent strategies and prosecution activities, he also advises clients on intellectual property due diligences, freedom-to-operate and risk assessments, and intellectual property agreements, including collaboration and license agreements.

Dr. Greenhalgh has been consistently recognized as a leading life science patent attorney by numerous legal guides. Chambers USA recognized him for being “particularly adept at advising life sciences companies on IP and market strategy” and noted that he is “great at finding solutions and has good business acumen.”

JD, Suffolk University Law School 1998 (magna cum laude); PhD, Biochemistry, University of Leeds, UK 1989; BSc, Biotechnology, University of Leeds, UK 1985 (with honors)